{"entity":{"type":"insider","cik":"0001998173","url":"/insider/0001998173","json_url":"/insider/0001998173.json","name":"Fox Christine","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2024-11-21","last":"2026-05-04","span_basis":"filed_date"},"name_variants":[{"name":"Fox Christine","source":"filing","n_filings":7,"first_seen":"2024-11-21","last_seen":"2026-05-04"}],"transactions":[{"id":5837272,"accession":"0001193125-26-203920","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-203920","line_url":"/filing/0001193125-26-203920#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001998173","owner_name":"Fox Christine","owner_display_name":"Fox Christine","owner_url":"/insider/0001998173","role":"Officer (EVP, U.S. Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, U.S. Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, U.S. Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21258.0,"shares_display":"21,258","price_per_share":35.31,"price_display":"35.31","price_state":"stated","total_value":750619.98,"total_display":"750,619.98","total_whole":"750,620","shares_owned_after":63647.0,"shares_owned_after_display":"63,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-30","filed_date":"2026-05-04","scope":"insider"},{"id":5822631,"accession":"0001193125-26-098541","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-098541","line_url":"/filing/0001193125-26-098541#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001998173","owner_name":"Fox Christine","owner_display_name":"Fox Christine","owner_url":"/insider/0001998173","role":"Officer (EVP, U.S. Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, U.S. Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, U.S. Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7924.0,"shares_display":"7,924","price_per_share":31.6684,"price_display":"31.67","price_state":"stated","total_value":250940.4016,"total_display":"250,940.40","total_whole":"250,940","shares_owned_after":84905.0,"shares_owned_after_display":"84,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-09","scope":"insider"},{"id":6001456,"accession":"0001193125-26-096498","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-096498","line_url":"/filing/0001193125-26-096498#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001998173","owner_name":"Fox Christine","owner_display_name":"Fox Christine","owner_url":"/insider/0001998173","role":"Officer (EVP, U.S. Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, U.S. Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, U.S. Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9098.0,"shares_display":"9,098","price_per_share":32.4645,"price_display":"32.46","price_state":"stated","total_value":295362.021,"total_display":"295,362.02","total_whole":"295,362","shares_owned_after":75010.0,"shares_owned_after_display":"75,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":4941142,"accession":"0001193125-25-293655","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-293655","line_url":"/filing/0001193125-25-293655#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001998173","owner_name":"Fox Christine","owner_display_name":"Fox Christine","owner_url":"/insider/0001998173","role":"Officer (EVP, Head of U.S. Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Head of U.S. Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of U.S. Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28229.0,"shares_display":"28,229","price_per_share":24.7803,"price_display":"24.78","price_state":"stated","total_value":699523.0887,"total_display":"699,523.09","total_whole":"699,523","shares_owned_after":63647.0,"shares_owned_after_display":"63,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-20","filed_date":"2025-11-24","scope":"insider"},{"id":4623851,"accession":"0001193125-25-286134","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-286134","line_url":"/filing/0001193125-25-286134#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001998173","owner_name":"Fox Christine","owner_display_name":"Fox Christine","owner_url":"/insider/0001998173","role":"Officer (EVP, Head of U.S. Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Head of U.S. Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of U.S. Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":25.1107,"price_display":"25.11","price_state":"stated","total_value":753321.0,"total_display":"753,321.00","total_whole":"753,321","shares_owned_after":28384.0,"shares_owned_after_display":"28,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-14","filed_date":"2025-11-18","scope":"insider"},{"id":4712262,"accession":"0000950170-25-034687","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-034687","line_url":"/filing/0000950170-25-034687#line-3","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001998173","owner_name":"Fox Christine","owner_display_name":"Fox Christine","owner_url":"/insider/0001998173","role":"Officer (EVP, Head of U.S. Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Head of U.S. Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of U.S. Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2147.0,"shares_display":"2,147","price_per_share":15.9132,"price_display":"15.91","price_state":"stated","total_value":34165.6404,"total_display":"34,165.64","total_whole":"34,166","shares_owned_after":58384.0,"shares_owned_after_display":"58,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-06","scope":"insider"},{"id":4712254,"accession":"0000950170-25-034687","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-034687","line_url":"/filing/0000950170-25-034687#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001998173","owner_name":"Fox Christine","owner_display_name":"Fox Christine","owner_url":"/insider/0001998173","role":"Officer (EVP, Head of U.S. Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Head of U.S. Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of U.S. Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4034.0,"shares_display":"4,034","price_per_share":15.7346,"price_display":"15.73","price_state":"stated","total_value":63473.3764,"total_display":"63,473.38","total_whole":"63,473","shares_owned_after":60531.0,"shares_owned_after_display":"60,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-06","scope":"insider"},{"id":2125635,"accession":"0000950170-24-129709","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-129709","line_url":"/filing/0000950170-24-129709#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001998173","owner_name":"Fox Christine","owner_display_name":"Fox Christine","owner_url":"/insider/0001998173","role":"Officer (EVP, Head of U.S. Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Head of U.S. Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of U.S. Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19388.0,"shares_display":"19,388","price_per_share":16.8705,"price_display":"16.87","price_state":"stated","total_value":327085.254,"total_display":"327,085.25","total_whole":"327,085","shares_owned_after":44104.0,"shares_owned_after_display":"44,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","url":"/issuer/0000818686","role":"Officer (EVP, U.S. Commercial)","n_filings":7,"first_seen":"2024-11-21","last_seen":"2026-05-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001998173","retrieved_at":"2026-08-22T09:38:37+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}